A Study in Adult Subjects With Select Advanced Solid Tumors

DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer

NCT05680922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma

NCT00576641 ·Status: COMPLETED ·Phase: PHASE1

MESA Treatment for NK/T Cell Lymphoma

NCT01933282 ·Status: UNKNOWN ·Phase: PHASE2

Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells

NCT00186316 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

NCT05292859 ·Status: COMPLETED

Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer

NCT00272649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of γδ T Cell Against Gastric Cancer

NCT02585908 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Melanoma Patients Immunized with Natural DenDritic Cells

NCT02993315 ·Status: COMPLETED ·Phase: PHASE3

Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer

NCT00005816 ·Status: COMPLETED ·Phase: PHASE1

a Single-arm, Single-center, Open Clinical Study

NCT06431100 ·Status: RECRUITING

Biological Therapy in Treating Patients With Advanced Cancer

NCT00005956 ·Status: COMPLETED ·Phase: NA

Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy

NCT03548571 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

NCT00576537 ·Status: COMPLETED ·Phase: PHASE2

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03735589 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

NCT02411786 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant

NCT04815356 ·Status: RECRUITING ·Phase: PHASE1

Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine

NCT04672473 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults

NCT02496520 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer

NCT01826877 ·Status: COMPLETED ·Phase: PHASE1

Tumor RNA Transfected Dendritic Cell Vaccines

NCT00108264 ·Status: COMPLETED ·Phase: PHASE1

Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.

NCT02718391 ·Status: TERMINATED ·Phase: PHASE2

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

NCT05238792 ·Status: RECRUITING ·Phase: PHASE1

Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer

NCT00050323 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma

NCT00937183 ·Status: COMPLETED ·Phase: NA

A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)

NCT00611208 ·Status: COMPLETED ·Phase: PHASE2